Adhesive companys low price scrip stock of 2009 now becomes gold mine for investors!
Adhesive companys low price scrip stock of 2009 now becomes gold mine for investors!

Adhesive companys low price scrip stock of 2009 now becomes gold mine for investors!

Geyatee Deshpande Article rating: 3.9

The scrip of Pidilite Industries, which was one of the low price scrip stocks trading under Rs 100 per share in 2009, has jumped by more than 4,000 per cent, which is quite phenomenal! On Friday, the shares of Pidilite Industries made a fresh all-time high of Rs 1,992.10 per share.   

 

In interaction with Niraj Kumar, Chief Investment Officer, Future Generali India Life Insurance Co. Ltd
In interaction with Niraj Kumar, Chief Investment Officer, Future Generali India Life Insurance Co. Ltd

In interaction with Niraj Kumar, Chief Investment Officer, Future Generali India Life Insurance Co. Ltd

Geyatee Deshpande Article rating: 3.8

Despite the second wave of the corona virus resulting in localised lockdowns across the country and creating an economic setback for businesses, Niraj Kumar, Chief Investment Officer, Future Generali India Life Insurance Co. Ltd., is quite optimistic about the overall scenario.

Join us for an exclusive interview with Mr Saransh Chaudhary, President, Critical Care Division, Venus Remedies
Join us for an exclusive interview with Mr Saransh Chaudhary, President, Critical Care Division, Venus Remedies

Join us for an exclusive interview with Mr Saransh Chaudhary, President, Critical Care Division, Venus Remedies

Geyatee Deshpande Article rating: 4.6

"Our top three strategic priorities include forging synergic partnerships for our leading generic & research products, optimising organisational leverage to maximise our gains as well as astute capital investment", says Mr Saransh Chaudhary, CEO, Venus Medicine Research Centre (VMRC), and President, Critical Care Division, Venus Remedies in an exclusive interview with Geyatee Deshpande, Senior Research Associate, Dalal Street Investment Journal.  

Welspun India targets US markets with Target Corporation, board approves buyback & much more!
Welspun India targets US markets with Target Corporation, board approves buyback & much more!

Welspun India targets US markets with Target Corporation, board approves buyback & much more!

Geyatee Deshpande Article rating: 4.7

In a press release, Welspun India stated that the company is set to work with Target Corporation in the USA to achieve business growth. Reacting to the announcements made post the meeting held of its board of directors, its stock jumped by more than 11 per cent. 

Buzzing stock: UPL zooms more than 8 per cent
Buzzing stock: UPL zooms more than 8 per cent

Buzzing stock: UPL zooms more than 8 per cent

Geyatee Deshpande Article rating: 4.3

The shares of UPL Ltd climbed over 8 per cent on Friday, touching its 52-week high of Rs 764.45 per share, after JP Morgan released a coverage report on the company, highlighting its growth potential. 

Lupin announces dividend for FY21; sales decline in Q4FY21
Lupin announces dividend for FY21; sales decline in Q4FY21

Lupin announces dividend for FY21; sales decline in Q4FY21

Geyatee Deshpande Article rating: 3.8

Pharmaceutical major Lupin announced that the company’s board of directors has recommended a dividend at 325 per cent equivalent to Rs 6.50 per equity share of the face value of Rs 2 each for FY21.  

Chennai Metro Rail Limited awards contract to HCC-KEC
Chennai Metro Rail Limited awards contract to HCC-KEC

Chennai Metro Rail Limited awards contract to HCC-KEC

Geyatee Deshpande Article rating: 4.0

Hindustan Construction Company (HCC) in a joint venture with KEC International Limited (KEC) has been awarded a contract worth Rs 1,147 crore by Chennai Metro Rail Limited (CMRL). 

RSS
124678910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR